Cargando…
Targeting Metabolic Remodeling in Triple Negative Breast Cancer in a Murine Model
Background: Chemotherapy is the backbone of systemic treatment for triple negative breast cancer (TNBC), which is one of the most relevant breast cancers molecular types due to the ability of tumor cells to develop drug resistance, highlighting the urgent need to design newer and safer drug combinat...
Autores principales: | García-Castillo, Verónica, López-Urrutia, Eduardo, Villanueva-Sánchez, Octavio, Ávila-Rodríguez, Miguel Á., Zentella-Dehesa, Alejandro, Cortés-González, Carlo, López-Camarillo, César, Jacobo-Herrera, Nadia J, Pérez-Plasencia, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327367/ https://www.ncbi.nlm.nih.gov/pubmed/28243322 http://dx.doi.org/10.7150/jca.16387 |
Ejemplares similares
-
Non-Coding RNAs Associated With Radioresistance in Triple-Negative Breast Cancer
por: Aranza-Martínez, Alberto, et al.
Publicado: (2021) -
Selective Acetogenins and Their Potential as Anticancer Agents
por: Jacobo-Herrera, Nadia, et al.
Publicado: (2019) -
MicroRNAs in Cervical Cancer: Evidences for a miRNA Profile Deregulated by HPV and Its Impact on Radio-Resistance
por: Pedroza-Torres, Abraham, et al.
Publicado: (2014) -
Anti-inflammatory and Antitumor Activity of a Triple Therapy for a Colitis-Related Colorectal Cancer
por: Figueroa-González, Gabriela, et al.
Publicado: (2016) -
Negative Regulation of ULK1 by microRNA-106a in Autophagy Induced by a Triple Drug Combination in Colorectal Cancer Cells In Vitro
por: Salgado-García, Rebeca, et al.
Publicado: (2021)